Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-09-12

FDA Approved: CASODEX — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Casodex (bicalutamide) submitted by ANI Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Casodex (bicalutamide)

Snippet

SUPPL AP for CASODEX (BICALUTAMIDE)